Treatment Resistant Depression
Conditions
Keywords
treatment resistant depression
Brief summary
Clinical studies, with a distinct focus on treatment resistant depression, play a crucial role in evaluating the safety and effectiveness of novel treatments. These trials serve as instrumental means to determine whether new medications surpass conventional therapies, providing substantial evidence for their broader adoption. The primary objective is to meticulously scrutinize trial completion rates and voluntary withdrawals within this specific patient group.
Interventions
None listed
Sponsors
Power Life Sciences Inc.
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Diagnosis of treatment resistant depression * Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed * No prior treatment for treatment resistant depression
Exclusion criteria
* Enrolled in another research study * Inability to provide written informed consent * Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of patients who decide to enroll in a treatment resistant depression clinical research. | 3 months |
| Number of treatment resistant depression study participants who remain in clinical study until completion. | 12 months |
Countries
United States
Contacts
Primary ContactMichael B Gill
Outcome results
None listed